Livzon Pharmaceutical Group Co Ltd (Livzon), a subsidiary of Joincare Pharmaceutical Group Industry Co Ltd, is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The company provides preparation drug products, bulk medicines and intermediates and diagnostic reagents and equipment. Its products include menotropin injections, urofollitropin injections, perospirone hydrochloride tablets, and ranitidine bismuth citrate tablets, among others. Livzon offers diagnostic kits such as BV quick-test kits, anti-HCV rapid tests, diagnostic kits, anti-HAV IgM ELISA kit, anti-TOXO IgG ELISA and HBsAg ELISA kits. The company offers drugs for various therapeutic areas such as antibiotics, antibacterial, gastrointestinal, psychotropic, antiviral, immunomodulation, anti-allergic and traditional Chinese medicine. Livzon is headquartered in Zhuhai, China.
Headquarters
China
Address
No. 38, Chuangye North Road, Zhuhai, Guangdong, 519090
Website
www.livzon.com.cn
Telephone
86 756 8135888
No of Employees
9,005
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
000513 (SHE)
Revenue (2022)
$1.9B
4.7%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
7.5%
(2022 vs 2021)
Market Cap*
$3.8B
Net Profit Margin (2022)
XYZ
2.7%
(2022 vs 2021)
* As of and is in US$
Livzon Pharmaceutical Group Co Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Gastrointestinal Drugs: |
| Domperidone Tablets |
| Bismuth Potassium Citrate Tablets |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Acquisitions/Mergers/Takeovers | In November, the company acquired an additional 5% stake in Livzon Diagnostics. |
| 2023 | Plans/Strategy | In November, the company announced its plans to acquire an additional 7.7% stake in Livzon Diagnostics. |
| 2023 | Contracts/Agreements | In July, the company entered into the Patent and Technology Transfer Agreement with Shanghai Synergy Pharmaceutical Sciences Co., Ltd, under which Synergy Pharmaceutical Sciences agreed to assign and transfer all rights, titles and interests of its HHT120 project. |
Competitor Comparison
| Key Parameters | Livzon Pharmaceutical Group Co Ltd | Sinopharm Group Co Ltd | China National Accord Medicines Corporation Ltd | Tianjin Chase Sun Pharmaceutical Co Ltd | Beijing Tiantan Biological Products Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Zhuhai | Shanghai | Shenzhen | Tianjin | Beijing |
| State/Province | Guangdong | Shanghai | Guangdong | Tianjin | Beijing |
| No. of Employees | 9,005 | 113,362 | 39,296 | 6,146 | 4,568 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Zhu Baoguo | Chairman | Executive Board | 2005 | 61 |
| Tao Desheng | Vice Chairman | Executive Board | 2014 | 58 |
| Xu Guoxiang | Vice President; Vice Chairman | Executive Board | 2019 | 61 |
| Tang Yanggang | President; Director | Executive Board | 2019 | 54 |
| Si Yanxia | Vice President; Chief Financial Officer | Senior Management | 2014 | 54 |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward